9:22 AM
Leo Group India
| ||
| Millennium Pharmaceuticals Cambridge expansion tests triggers backlash at ... Boston.com That opposition has already scored one major victory: stalling a proposed 246,000-square-foot office and lab complex near Central Square that would house drug maker Millennium Pharmaceuticals. And now more development could be in question as ... See all stories on this topic » | ||
| Guj pharma cos pip slowdown on FII pill Daily News & Analysis Defying the downturn trend on stock exchanges, pharmaceutical companies have once again proven to be defensive stocks. Share prices of six Gujarat-based pharmaceutical companies have not only touched their 52-week high in August, but have also ... See all stories on this topic » | ||
| US FDA approves Watson Pharma's lidocaine topical patch 5% pharmabiz.com The United States Food and Drug Administration (FDA) has granted final approval to Watson Pharmaceuticals' Abbreviated New Drug Application (ANDA) for lidocaine topical patch five per cent, the generic equivalent to Endo's Lidoderm. Watson plans to ... See all stories on this topic » | ||
| NPS Pharmaceuticals: A Strong Near-Term Catalyst Seeking Alpha NPS Pharmaceuticals (NPSP) is a biopharmaceutical company focused on bringing orphan products to patients with rare disorders and few, if any, therapeutic options. NPS is advancing two late-stage registration programs. A New Drug Application is ... See all stories on this topic » | ||
| FIPB gives nod to eight pharma FDI proposals Times of India Organisation of Pharmaceutical Producers of India (OPPI), the lobby body of foreign pharma companies in India, has welcomed the move. "This is a one small step for encouraging FDI in India," said OPPI president Ranjit Shahani, adding that similar ... See all stories on this topic » | ||
| Watson Pharmaceuticals Incorporated Stock Rating Reaffirmed by Leerink ... Jags Report Watson Pharmaceuticals Incorporated traded up 5.61% on Friday, hitting $83.04. Watson Pharmaceuticals Incorporated has a 1-year low of $55.00 and a 1-year high of $81.00. The company has a market cap of $10.600 billion and a price-to-earnings ratio of ... See all stories on this topic » | ||
| Healthcare Review: Watson Pharmaceuticals, Pozen, Discovery Laboratories ... Pharmaceutical Processing Watson Pharmaceuticals, Inc. (NYSE:WPI) stock climbed 4.12% to $81.87 after the company announced that its subsidiary, Watson Laboratories, Inc., has received final approval from the United States Food and Drug Administration (FDA) on its Abbreviated ... See all stories on this topic » | ||
| West Sets Up New Facility in India - Analyst Blog NASDAQ West Pharmaceutical Services' ( WST ) indirect subsidiary, West Pharmaceutical India Packaging Private Ltd., has commenced the construction of a new compression molding facility in Sri City, India. The facility will be a quantum of the company's global ... See all stories on this topic » | ||
| Watson Stock Hits High On Generic Lidoderm Approval Investor's Business Daily Shares of Watson Pharmaceuticals (WPI) hit a new all-time high Friday after the company received FDA approval for a generic version of Lidoderm. Watson announced Thursday that it would begin selling the product, which delivers the painkiller lidocaine ... See all stories on this topic » | ||
| Arena Is Poised To Move Seeking Alpha Investors in Arena Pharmaceuticals, Inc. (ARNA) got great news in late June that the company's obesity drug Belviq had received FDA approval. A combination of excitement and irrational exuberance then took over and sent Arena toward a 52-week high of ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment